HCCs with mutations in the CTNNB1 gene (CT-HCC) exhibit a distinct phenotype with well-differentiated tumors, microtrabecular and pseudoglandular architectural patterns, intratumoral cholestasis, and absent or low lymphocytic infiltration16, 17. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.